Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cbd cannabidiol:

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Burstein S et al. Bioorg Med Chem. (2015)

Cannabidiol, neuroprotection and neuropsychiatric disorders. Campos AC et al. Pharmacol Res. (2016)

The Utility of Cannabidiol in the Treatment of Refractory Epilepsy. Reddy DS et al. Clin Pharmacol Ther. (2017)

Search results

Items: 1 to 20 of 1209

1.

Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.

Miller S, Daily L, Leishman E, Bradshaw H, Straiker A.

Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5904-5911. doi: 10.1167/iovs.18-24838.

PMID:
30550613
2.

Chemical characterization of leaves, male and female flowers from spontaneous cannabis (Cannabis sativa var. spontanea) growing in Hungary.

Nagy DU, Cianfaglione K, Maggi F, Sut S, Dall'Acqua S.

Chem Biodivers. 2018 Dec 13. doi: 10.1002/cbdv.201800562. [Epub ahead of print]

PMID:
30548994
3.

Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.

Elms L, Shannon S, Hughes S, Lewis N.

J Altern Complement Med. 2018 Dec 13. doi: 10.1089/acm.2018.0437. [Epub ahead of print]

PMID:
30543451
4.

Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.

Szkudlarek HJ, Desai SJ, Renard J, Pereira B, Norris C, Jobson CEL, Rajakumar N, Allman BL, Laviolette SR.

Neuropsychopharmacology. 2018 Nov 27. doi: 10.1038/s41386-018-0282-7. [Epub ahead of print]

PMID:
30538288
5.

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.

Millar SA, Stone NL, Yates AS, O'Sullivan SE.

Front Pharmacol. 2018 Nov 26;9:1365. doi: 10.3389/fphar.2018.01365. eCollection 2018.

6.

Simultaneous quantification of thirteen cannabinoids and metabolites in human plasma by liquid chromatography tandem mass spectrometry in adult epilepsy patients.

Roslawski MJ, Remmel RP, Karanam A, Leppik IE, Marino SE, Birnbaum AK.

Ther Drug Monit. 2018 Dec 4. doi: 10.1097/FTD.0000000000000583. [Epub ahead of print]

PMID:
30520828
7.

Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D.

Leishman E, Manchanda M, Thelen R, Miller S, Mackie K, Bradshaw HB.

Cannabis Cannabinoid Res. 2018 Nov 30;3(1):228-241. doi: 10.1089/can.2018.0031. eCollection 2018.

8.

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.

Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.

Mult Scler Relat Disord. 2018 Nov 20;27:383-390. doi: 10.1016/j.msard.2018.11.022. [Epub ahead of print]

PMID:
30502644
9.

Emerging drugs for the treatment of Dravet syndrome.

Brigo F, Striano P, Balagura G, Belcastro V.

Expert Opin Emerg Drugs. 2018 Nov 27. doi: 10.1080/14728214.2018.1552937. [Epub ahead of print]

PMID:
30482063
10.

Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma.

Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JE, Zuardi AW, Crippa JA, Reis C, Bahl M, Pizzichinni E, Maurici R, Pizzichinni MMM, Rocco PRM, Dal-Pizzol F.

Eur J Pharmacol. 2018 Nov 24;843:251-259. doi: 10.1016/j.ejphar.2018.11.029. [Epub ahead of print]

PMID:
30481497
11.

Novel inverse agonists for the orphan G protein-coupled receptor 6.

Laun AS, Shrader SH, Song ZH.

Heliyon. 2018 Nov 16;4(11):e00933. doi: 10.1016/j.heliyon.2018.e00933. eCollection 2018 Nov.

12.

Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.

Aparicio-Blanco J, Sebastián V, Benoit JP, Torres-Suárez AI.

Eur J Pharm Biopharm. 2019 Jan;134:126-137. doi: 10.1016/j.ejpb.2018.11.020. Epub 2018 Nov 22.

PMID:
30472144
13.

Impact of recreational and medicinal marijuana on surgical patients: A review.

Bakshi C, Barrett AM.

Am J Surg. 2018 Nov 14. pii: S0002-9610(18)31123-1. doi: 10.1016/j.amjsurg.2018.10.053. [Epub ahead of print] Review.

PMID:
30471810
14.

Epilepsy and Cannabis: A Literature Review.

Zaheer S, Kumar D, Khan MT, Giyanwani PR, Kiran F.

Cureus. 2018 Sep 10;10(9):e3278. doi: 10.7759/cureus.3278. Review.

15.

The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids.

Poklis JL, Mulder HA, Peace MR.

Forensic Sci Int. 2018 Nov 1. pii: S0379-0738(18)30704-7. doi: 10.1016/j.forsciint.2018.10.019. [Epub ahead of print]

PMID:
30442388
16.

Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.

Santiago AN, Mori MA, Guimarães FS, Milani H, Weffort de Oliveira RM.

Neurotox Res. 2018 Nov 14. doi: 10.1007/s12640-018-9972-5. [Epub ahead of print]

PMID:
30430393
17.

Cannabis Systematics at the Levels of Family, Genus, and Species.

McPartland JM.

Cannabis Cannabinoid Res. 2018 Oct 1;3(1):203-212. doi: 10.1089/can.2018.0039. eCollection 2018. Review.

18.

A UHPLC-MS/MS method for the quantification of Δ9-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis.

Barco S, Fucile C, Manfredini L, Grandis E, Gherzi M, Martelli A, Tripodi G, Mattioli F, Cangemi G.

Bioanalysis. 2018 Nov 6. doi: 10.4155/bio-2018-0184. [Epub ahead of print]

PMID:
30412688
19.

Cannabis Therapeutics and the Future of Neurology.

Russo EB.

Front Integr Neurosci. 2018 Oct 18;12:51. doi: 10.3389/fnint.2018.00051. eCollection 2018.

20.

Efficacy of cannabinoids in paediatric epilepsy.

Ali S, Scheffer IE, Sadleir LG.

Dev Med Child Neurol. 2019 Jan;61(1):13-18. doi: 10.1111/dmcn.14087. Epub 2018 Nov 6. Review.

PMID:
30402932

Supplemental Content

Loading ...
Support Center